SK bioscience

www.skbioscience.com

SK bioscience is a leading South Korean vaccine and biotech company with innovative R&D and cutting-edge manufacturing systems. SK bioscience developed South Korea's first COVID-19 vaccine, 'SKYCovione' through global cooperation with the Bill & Melinda Gates Foundation, CEPI, GSK, etc., and a universal vaccine to prevent ‘Sarbecovirus.’ SK bioscience developed the world's first quadrivalent cell-cultured influenza vaccine, SKYCellflu with obtaining WHO PQ (Pre-qualification) certification in 2019 followed by developing SKYZoster, the world's second shingles vaccine, and SkyVaricella, the world's second WHO PQ-certified chickenpox vaccine. SK bioscience is expanding its R&D pipeline through global partnerships with public and private institutions, and is planning to commercialize a pneumococcal conjugate vaccine, cervical cancer vaccine, typhoid conjugate vaccine, and rotavirus vaccine. In the recent COVID-19 pandemic, SK bioscience has established a fast pandemic response system and has grown into a global vaccine company attracting attention in the world. In addition, SK bioscience signed a CMO contract to manufacture AstraZeneca's COVID-19 vaccine from drug substance to drug product at L-House, SK’s vaccine manufacturing plant, and contributed to the early prevention of COVID-19, recognized as a global hub for vaccine manufacturing. Based on its technology, all SK bioscience colleagues are trying to achieve the company’s mission, ‘We promote human health, from prevention to cure.’ To meet social expectations, SK bioscience will build trust as a global innovative partner of vaccine and biotech so that all stakeholders, including employees, customers, shareholders, and local communities, could be proud and happy.

Read more

Reach decision makers at SK bioscience

Lusha Magic

Free credit every month!

SK bioscience is a leading South Korean vaccine and biotech company with innovative R&D and cutting-edge manufacturing systems. SK bioscience developed South Korea's first COVID-19 vaccine, 'SKYCovione' through global cooperation with the Bill & Melinda Gates Foundation, CEPI, GSK, etc., and a universal vaccine to prevent ‘Sarbecovirus.’ SK bioscience developed the world's first quadrivalent cell-cultured influenza vaccine, SKYCellflu with obtaining WHO PQ (Pre-qualification) certification in 2019 followed by developing SKYZoster, the world's second shingles vaccine, and SkyVaricella, the world's second WHO PQ-certified chickenpox vaccine. SK bioscience is expanding its R&D pipeline through global partnerships with public and private institutions, and is planning to commercialize a pneumococcal conjugate vaccine, cervical cancer vaccine, typhoid conjugate vaccine, and rotavirus vaccine. In the recent COVID-19 pandemic, SK bioscience has established a fast pandemic response system and has grown into a global vaccine company attracting attention in the world. In addition, SK bioscience signed a CMO contract to manufacture AstraZeneca's COVID-19 vaccine from drug substance to drug product at L-House, SK’s vaccine manufacturing plant, and contributed to the early prevention of COVID-19, recognized as a global hub for vaccine manufacturing. Based on its technology, all SK bioscience colleagues are trying to achieve the company’s mission, ‘We promote human health, from prevention to cure.’ To meet social expectations, SK bioscience will build trust as a global innovative partner of vaccine and biotech so that all stakeholders, including employees, customers, shareholders, and local communities, could be proud and happy.

Read more
icon

Country

icon

Employees

1001-5000

icon

Founded

2018

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Vice President , Global Business Development , Sk Bioscience

    Email ****** @****.com
    Phone (***) ****-****
  • Executive Vice President Vaccines Research and Development Strategy and External Innovation

    Email ****** @****.com
    Phone (***) ****-****
  • Vice President of Research and Development Project Management

    Email ****** @****.com
    Phone (***) ****-****
  • President and Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(8)

Reach decision makers at SK bioscience

Free credits every month!

My account

Sign up now to uncover all the contact details